Cancer Letters
Volume 234, Issue 2 , Pages 135-142 , 28 March 2006

Inhibitory effect of the tea polyphenol, (−)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines

Received 3 February 2005 ,Revised 15 March 2005 ,Accepted 17 March 2005.

References 

  1. Valcic S, Timmermann BN, Alberts DS, Wachter GA, Krutzsch M, Wymer J, et al. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs. 1996;7:461–468
  2. Khafif A, Schantz SP, Chou TC, Edelstein D, Sacks PG. Quantitation of chemopreventive synergism between (−)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 1998;19:419–424
  3. Chen ZP, Schell JB, Ho CT, Chen KY. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 1998;129:173–179
  4. Tobi SE, Gilbert M, Paul N, McMillan TJ. The green tea polyphenol, epigallocatechin-3-gallate, protects against the oxidative cellular and genotoxic damage of UVA radiation. Int. J. Cancer. 2002;102:439–444
  5. Katiyar SK, Bergamo BM, Vyalil PK, Elmets CA. Green tea polyphenols: DNA photodamage and photoimmunology. J. Photochem. Photobiol. B. 2001;65:109–114
  6. Gensler HL, Timmermann BN, Valcic S, Wachter GA, Dorr R, Dvorakova K, et al. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutr. Cancer. 1996;26:325–335
  7. Fujiki H, Suganuma M, Okabe S, Sueoka N, Komori A, Sueoka E, et al. Cancer inhibition by green tea. Mutat. Res. 1998;402:307–310
  8. Lung HL, Ip WK, Wong CK, Mak NK, Chen ZY, Leung KN. Anti-proliferative and differentiation-inducing activities of the green tea catechin epigallocatechin-3-gallate (EGCG) on the human eosinophilic leukemia EoL-1 cell line. Life Sci. 2002;72:257–268
  9. Fujiki H, Suganuma M, Kurusu M, Okabe S, Imayoshi Y, Taniguchi S, et al. New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Mutat. Res. 2003;523–524:119–125
  10. Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, Rogers AE, et al. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell Biochem. 2001;82:387–398
  11. Stammler G, Volm M. Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines. Anticancer Drugs. 1997;8:265–268
  12. Yokoyama S, Hirano H, Wakimaru N, Sarker KP, Kuratsu J. Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro. Neuro-oncology. 2001;3:22–28
  13. Naasani I, Oh-Hashi F, Oh-Hara T, Feng WY, Johnston J, Chan K, et al. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 2003;63:824–830
  14. Naasani I, Seimiya H, Tsuruo T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem. Biophys. Res. Commun. 1998;249:391–396
  15. Yokoyama M, Noguchi M, Nakao Y, Pater A, Iwasaka T. The tea polyphenol, (−)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. Gynecol. Oncol. 2004;92:197–204
  16. Wang SS, Sherman ME, Hildesheim A, Lacey JV, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer. 2004;100:1035–1044
  17. Leung TW, Xue WC, Cheung AN, Khoo US, Ngan HY. Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix. Gynecol. Oncol. 2004;92:866–872
  18. Baalbergen A, Ewing-Graham PC, Hop WC, Struijk P, Helmerhorst TJ. Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol. Oncol. 2004;92:262–267
  19. Balega J, Michael H, Hurteau J, Moore DH, Santiesteban J, Sutton GP, et al. The risk of nodal metastasis in early adenocarcinoma of the uterine cervix. Int. J. Gynecol. Cancer. 2004;14:104–109
  20. Yamada T, Ueda M, Maeda T, Miyawaki Y, Misaki O, Ueki M, et al. Establishment and characterization of a cell line (OMC-4) originating from a human adenocarcinoma of the uterine cervix. Nippon Sanka Fujinka Gakkai Zasshi. 1987;39:859–860
  21. Zheng PS, Iwasaka T, Ouchida M, Fukuda K, Yokoyama M, Sugimori H. Growth suppression of a cervical cancer cell line (TMCC-1) by the human wild-type p53 gene. Gynecol. Oncol. 1996;60:245–250
  22. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015
  23. Yokoyama M, Nakao Y, Iwasaka T, Pater A, Sugimori H. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines. Obstet. Gynecol. 2001;98:332–340
  24. Hara K, Iwasaka T, Matsuo N, Nakao Y, Yokoyama M, Yamasaki F, et al. Effects of single and combined application of anti-cancer drugs on cervical adenocarcinoma. I. Anti-tumor activity in vitro. Acta Obstet. Gynecol. Scand. 1995;74:330–335
  25. Schneider Y, Fischer B, Coelho D, Roussi S, Gosse F, Bischoff P, et al. (Z)-3,5,4′-Tri-O-methyl-resveratrol, induces apoptosis in human lymphoblastoid cells independently of their p53 status. Cancer Lett. 2004;211:155–161
  26. Liberto M, Cobrinik D. Growth factor-dependent induction of p21(CIP1) by the green tea polyphenol, epigallocatechin gallate. Cancer Lett. 2000;154:151–161
  27. Ahmad N, Cheng P, Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun. 2000;275:328–334
  28. Berger SJ, Gupta S, Belfi CA, Gosky DM, Mukhtar H. Green tea constituent (−)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochem. Biophys. Res. Commun. 2001;288:101–105
  29. Suzuki K, Yahara S, Hashimoto F, Uyeda M. Inhibitory activities of (−)-epigallocatechin-3-O-gallate against topoisomerases I and II. Biol. Pharm. Bull. 2001;24:1088–1090
  30. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 2000;182:311–322
  31. MacCallum DE, Hall PA. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J. Pathol. 2000;190:537–544
  32. Bridger JM, Kill IR, Lichter P. Association of pKi-67 with satellite DNA of the human genome in early G1 cells. Chromosome Res. 1998;6:13–24
  33. Elias E, Lalun N, Lorenzato M, Blache L, Chelidze P, O'Donohue MF, et al. Cell-cycle-dependent three-dimensional redistribution of nuclear proteins, P 120, pKi-67, and SC 35 splicing factor, in the presence of the topoisomerase I inhibitor camptothecin. Exp. Cell Res. 2003;291:176–188
  34. Webb T. Green tea experiments in lab, clinic yields mixed results. J. Natl Cancer Inst. 2000;92:1038–1039

PII: S0304-3835(05)00270-3

doi: 10.1016/j.canlet.2005.03.053

Cancer Letters
Volume 234, Issue 2 , Pages 135-142 , 28 March 2006

Article Tools

* Image Usage & Resolution